HIV Molecular Immunology Database
Databases
Sequence DB
Immunology DB
Neutralization DB
Ab contacts DB
HCV Databases
HFV Databases
Search
CTL/CD8+ Search
T Helper/CD4+ Search
Antibody Search
CTL Variant Search
T Helper Variant Search
Patient Search
JSON API Information
Search Help
Old Search
Tools
All Immunology Tools
CATNAP
CombiNAber
HIV Genome Browser
Quickalign
CAByN
Analyze Align
Alignment Slicer
PeptGen
PepMap
Motif Scan
Hepitope
HLA Freq Analysis
ELF
Sequence Locator
SeqPublish
Heatmap
Epigraph Vaccine Suite
Mosaic Vaccine Suite
N-Glycosite
Highlighter
Protein Feature Accent
Variable Region
Neutralization Index
Products
Epitope Maps
Epitope & Antibody Tables
Epitope Alignments
Epitope Density Plots
T-Cell Epitope Variants
Neutralizing Ab Resources
& CATNAP
Data Sets: HLA Typing and
Epitope Mapping
Tools & Links
Info
Compendia
Reviews
About the Database
FAQ
How to Cite this Database
Sequence Alignments
Database Tutorials
HIV Molecular Immunology Database Search
Antibody Search
Search Help
How to Find Information
HIV protein
-ALL-
Gag
p17
p24
p2p7p1p6
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
Env
Nef
Antisense protein (ASP)
HIV-1
HIV-2 proteins
SIV proteins
other non-HIV
HXB2 protein location
–
Results overlap with query location
Results contained within query location
Results exactly match query location
HXB2 DNA location
–
Results overlap with query location
Epitope
Results contain query sequence
Results exactly match query sequence
Results fuzzy match to query sequence
Epitope name
MAb name
Exact Match
(List by name)
(List by type)
Record number
Subtype
-ALL-
A
A1
AD
AG
B
BC
C
CRF01_AE
CRF02_AG
CRF07_BC
D
F
G
H
HIV-2
M group
multiple
O group
Immunogen
-ALL-
anti-idiotype
autoimmune disease
engineered
HIV-1 exposed seronegative
HIV-1 infection
HIV-2 infection
in vitro stimulation or selection
SHIV infection
SIV infection
vaccine
virus
Vaccine details
if Immunogen is Vaccine
Vaccine type
-ALL-
adenovirus
adenovirus 26 (Ad26)
adenovirus type 5 (Ad5)
AIDSVAX B/E
ALVAC-HIV
B. abortus complex
baculovirus
beta-galactosidase fusion protein
canarypox
canarypox prime with gp120 boost
canarypox prime with recombinant protein boost
chimeric GM-CSF
chimeric maltose binding protein (MBP)
chitosan nanoparticles
Con A-NS
Cowpea mosaic virus
DNA
DNA prime with Ad5 boost
DNA prime with gp120 boost
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with peptide boost
DNA prime with protein boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV/MCK hybrid promotor
DNA with CMV promotor
DNA with MCK promotor
fixed fusion-intermediate
formaldehyde-fixed whole-cell
fowlpoxvirus
fowlpoxvirus prime with virus-like particle (VLP) boost
gp120-CD4 complex
gp120 depleted whole killed virus
gp120-mAb A32 complex
gp140
gp140-CD4 complex
gp140F (fused form, no gp120–gp41 cleavage site)
HBcAg fusion
hepatitis B surface antigen lipoprotein particles (HsBAg)
HIV-1 captured on concavalin A-immobilized polystyrene nanospheres
HIV-1 immunogen
HIV infected-cell lysate
human rhinovirus 14
E. coli recombinant protein
E. coli Trp fusion protein
inactivated HIV
influenza
ISCOM
lipopeptide
liposome
measles virus (MV)
modified vaccinia Ankara (MVA)
nanoparticle
other
peptide
peptide Brucella abortus (Ba) conjugate
peptide in ISCOM
peptide in liposome
peptide keyhole limpet hemocyanin (KLH) conjugate
peptide lipopolysaccharide (LPS) conjugate
peptide presented on icosahedral protein scaffold
peptide prime with protein boost
PLG microparticle
poliovirus
polyepitope
protein
protein-Ab complex
purified HIV-1
recombinant protein
RV144
Salmonella
sCD4-gp120 complex
Semliki-Forest Virus
stabilized Env trimer
tetanus toxoid heavy chain fragment (rTTHC) conjugate
tetrameric Env
vaccinia
vaccinia prime with gp120 boost
Venezuelan equine encephalitis virus (VEE)
vesicular stomatitis virus (VSV)
vesicular stomatitis virus (VSV) with protein boost
viral lysate
virion
virus
virus derived protein
virus-like particle (VLP)
Vaccine strain
-ALL-
A clade
A clade 92RW020
A clade 92UG031
A clade BG505
A clade KNH1144
A clade UG37
A clade UG5.94UG018
AG recombinant HZ321
B clade
B clade 1007
B clade 89.6
B clade 89.6P
B clade 92US715
B clade ADA
B clade AGM TYO-7
B clade BaL
B clade BH10
B clade BH8
B clade BRU
B clade CAAN5342
B clade CBL-1
B clade consensus
B clade GNE8
B clade Gun-1
B clade HAN2
B clade HXB2
B clade HXB2/Bal
B clade HXBc2
B clade IIIB
B clade JMH-1
B clade JRFL
B clade LAI
B clade MN
B clade NL43
B clade Oyi
B clade R2
B clade RF
B clade SF162
B clade SF2
B clade SF33
B clade TH936705
B clade US005.11, FASH isolate
B clade US4
B clade W61D
B clade WITO4160
B clade YU2
C clade
C clade 426c
C clade 92BR025
C clade 96ZM651
C clade 97CN54
C clade 97ZA012
C clade CAP206
C clade CAP256
C clade CH505
C clade consensus
C clade Du422
C clade ZM106
CRF01 92TH023
CRF01 93TH976
CRF01 A244
CRF01 AA058
CRF01 AA104
CRF01 AA107
CRF01_AE clade
CRF01 CM235
CRF02_AG clade
CRF02 IC0928
D clade NDK
D clade UG21
D clade UG92005
E clade CM244
F clade BR29
HIV-2 ROD
HIV-2 SBL6669-ISY
M group consensus
Mosaic
multiple epitope immunogen
natural variants
O group HAM112
other
SIV
Vaccine component
-ALL-
anchored gp120
CD4bs
complete genome
deglycosylated gp120
desialylated gp160
Env
Env dimers
Env fragments in a pre-fusion state trimer
Env trimers
Env V3
Fusion Peptide - carrier protein conjugate
Gag
Gag-Pol
gp120
gp120ΔV1, V2, and V3
gp120-Mab complex
gp140
gp140ΔCFI
gp140ΔV1V2ΔCFImodifiedV3
gp140ΔV2
gp140ΔV3
gp160
gp160ΔCT
gp160ΔV3
gp41
gp41 MPER
heat-inactivated virus
HIV-1
Int
mimotopes
Nef
oligomeric gp140
other
p17 Gag
p17/p24 Gag
p24 Gag
p24-p15 Gag
p7 Gag
Pol
Protease
Rev
RT
Tat
Vif
virus
Vpr
Vpu
Adjuvant
-ALL-
Abisco-100
Adju-Phos
Adjuplex
adjuvant oily structure (IMS)
alpha2-macroglobin
aluminum hydroxide (alum)
aluminum phosphate
AS01B
AS02A
AS06 (CpG with aluminum hydroxide)
B7
block copolymer CRL8623
BSA
C3d fusion
Carbopol
cationic liposome
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
concavalin A-immobilized polystyrene nanospheres
CpG immunostimulatory sequence (ISS)
CpG oligodeoxynucleotides
E. coli heat labile enterotoxin
E. coli mutant heat labile enterotoxin (LT-R72)
ENABL C1 (VaxLiant)
GLA-SE (IDRI-EM107)
GM-CSF
GM-CSF/gp120 chimera
gp41 N-HR and C-HR helical peptides
GS
IFNγ
IL-12
IL-15
IL-18
IL-1α
IL-2
IL-2/Ig
IL-4
IL-7
IL-8
Immune stimulating complexes (ISCOM)
Incomplete Freund's Adjuvant (IFA)
Iscomatrix
Keyhole Limpit Haemocyanin (KLH)
lipid A
liposome
LTK63
macrophage activating lipopeptide-2 (MALP-2)
Matrix-M
M-CSF
MF59
monophosphoryl lipid A
Montanide (ISA 206)
Montanide (ISA 51)
Montanide (ISA 720)
MPL-SE adjuvant
muramyl-dipeptide base adjuvant (Syntex)
nitrocellulose
Other
phosphate calcium gel
phosphorothioate oligodeoxynucleotides (ODNs)
PLG
poly(I:C)
polyphosphazene
QS21
Quillaja saponin (Quil-A)
RANTES
red blood cells
Ribi adjuvant (MPL+TDM) (RIBI)
Sigma adjuvant system
trehalose dicorynomycolate
Tumor Necrosis Factor α (TNFα)
Tumor Necrosis Factor β (TNFβ)
Ab type
-ALL-
Antisense protein (ASP)
C-domain
C-HR
C-term
flap region
fusion peptide // near gp41-gp120 interface
gp120
gp120 adjacent to CD4bs
gp120 C1
gp120 C1-C2
gp120 C1-C4
gp120 C1-C5
gp120 C2
gp120 C2-C5
gp120 C3
gp120 C4
gp120 C5
gp120 CCR5bs
gp120 CD4bs
gp120-CD4 complex
gp120 CD4i
gp120 CD4i C1 (Cluster A)
gp120 CD4i C1 region
gp120 CD4i cluster A
gp120 CD4i cluster B
gp120 CD4i cluster C.1
gp120 CD4i cluster C.2
gp120 CD4i cluster C.3
gp120 CD4i cluster C.4
gp120 CD4i CoRbs (Cluster C)
gp120 close to CD4i
gp120 close to V3
gp120 core
gp120 core variable loops (VL)
gp120 glycans
gp120 glycosylation sites in C2, C3, C4, and V4
gp120 silent face
gp120 V1
gp120 V1-V2
gp120 V1-V2-V3
gp120 V2-CD4bs
gp120 V2 // V2 glycan(V2g) // V2 apex
gp120 V2-V3
gp120 V2V5 corridor
gp120 V3-C4
gp120 V3-C5
gp120 V3 discontinuous
gp120 V3 mimotope
gp120 V3 // V3 glycan (V3g)
gp120 V4
gp120 V5
gp120 V5-C5
gp41
gp41 adjacent to cluster II
gp41 CHR (C-heptad repeat)
gp41 cluster I
gp41 cluster II
gp41 cluster III
gp41 cytoplasmic domain
gp41 five-helix bundle (one CHR of six helix bundle missing)
gp41 fusion domain
gp41-gp120 interface
gp41-gp41 interface
gp41 MPER (membrane proximal external region)
gp41 NHR (N-heptad repeat)
gp41 six-helix bundle
gp41 six-helix bundle and the internal trimeric coiled-coil of N-helices
immunodominant region
Integrase catalytic core
Integrase DNA binding domain
Leucine zipper motif
non-HIV
non-HIV: host CCR5
non-HIV: host CD4R
N-term
p24+gp41
quaternary structure
RT palm domain
RT thumb domain
soluble Env trimer base
Tat basic region
Tat Cys-rich domain
Vif
Species
-ALL-
african green monkey
baboon
chimpanzee
cow
goat
guinea pig
hamster
human
humanized chimpanzee
humanized mouse
humanized rabbit
llama
macaque
mouse
rabbit
rat
scid-hu mouse
sheep
transgenic mouse
Isotype
-ALL-
IgA
IgA1
IgA2
IgA22a
IgE
IgG
IgG1
IgG1a
IgG1κ
IgG1λ
IgG2
IgG2a
IgG2aκ
IgG2b
IgG2bκ
IgG2κ
IgG2λ
IgG3
IgG3κ
IgG3λ
IgG4
IgGκ
IgM
IgMκ
IgMκ/λ
Author
Search only for
First
Last
Show only
this author's references
Show all references
Country
-ALL-
Australia
Belgium
Brazil
Cambodia
Cameroon
Canada
China
France
Gabon
Germany
Haiti
India
Italy
Japan
Kenya
Malawi
Netherlands
Peru
Russia
Rwanda
Senegal
South Africa
Sweden
Switzerland
Thailand
Trinidad and Tobago
Uganda
United Kingdom
United States
Zambia
Zimbabwe
Keywords
-ALL-
acute/early infection
adjuvant comparison
antibody binding site
antibody generation
antibody gene transfer
antibody interactions
antibody lineage
antibody polyreactivity
antibody sequence
anti-idiotype
assay or method development
autoantibody or autoimmunity
autologous responses
binding affinity
bispecific/trispecific
brain/CSF
broad neutralizer
CD4+ CTL
cell-line isolated antibody
chimeric antibody
chronic infection
compensatory mutation
complement
computational prediction
contact residues
co-receptor
cryptic epitope
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
effector function
elite controllers and/or long-term non-progressors
enhancing activity
escape
genital and mucosal immunity
germline
glycosylation
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HIV reservoir/latency/provirus
HLA associated polymorphism
immunodominance
immunomodulation
immunoprophylaxis
immunotherapy
immunotoxin
isotype switch
junction or fusion peptide
kinetics
memory cells
mimics
mimotopes
mother-to-infant transmission
mutation acquisition
neutralization
NK cells
non-susceptible form
novel epitope
optimal epitope
polyclonal antibodies
rate of progression
recombinant antibodies
responses in children
review
SIV
structure
subtype comparisons
superinfection
supervised treatment interruptions (STI)
Th1
Th2
therapeutic vaccine
transmission pair
vaccine antigen design
vaccine-induced immune responses
variant cross-reactivity
viral fitness and/or reversion
Show only
notes containing selected keyword(s)
Show all notes
Notes
Show only
notes matching this text
Show all notes
Questions or comments? Contact us at
immuno@lanl.gov